US › Healthcare

InfuSystems Holdings Inc (INFU)

US · Healthcare · Medical Devices

$13.69+0.96%

Last close · 2026-11-06

Latest quarter · ended 2026-09-30

Revenue

$37.6M

Revenue YoY

+3.0%

Net profit

$3.2M

Profit YoY

+39.7%

EPS

$0.15

EPS estimate

$0.12

Net margin

8.4%

EPS came in at 0.15 against a street estimate of 0.12 — a beat of 25.0%.

Key statistics

Market cap

$272.7M

P/E

31.1

Forward P/E

22.7

P/B

4.21

Book value

$2.84

EPS (TTM)

$0.44

52-week high

$14.64

52-week low

$7.29

50-day MA

$13.11

200-day MA

$10.45

Beta

1.38

Analyst view

Analysts rate InfuSystems Holdings Inc a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $16.83.

Shareholding

Insiders

7.27%

Institutions

85.11%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for InfuSystems Holdings Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.